{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T03:44:52Z","timestamp":1793677492785,"version":"4.5.1"},"reference-count":18,"publisher":"Wiley","issue":"8","license":[{"start":{"date-parts":[[2014,7,22]],"date-time":"2014-07-22T00:00:00Z","timestamp":1405987200000},"content-version":"vor","delay-in-days":3642,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Journal of Dermatology"],"published-print":{"date-parts":[[2004,8]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The complete treatment of anogenital warts has not been obtained with any combination of methods; therefore, new methods are still under investigation. In this study the activity and side effects of imiquimod 5% cream were investigated. The study group consisted of 23 male and 11 female volunteers and the control group of 9 male and 2 female volunteers. Patients applied the cream three times a week, every other day in the evenings for a period of 12 weeks. After the treatment, patients were regularly monitored for six months for recurrences. At the end of the study, 23 (69.7%) patients (all of females and 54.5% of males) in the study group displayed a complete clearance, 9 patients displayed 50\u201390% clearance and 1 patient displayed less than 50% clearance. In the control group, only 1 patient displayed a complete clearance, 1 patient displayed 50\u201390% clearance, and the other 8 patients showed no alteration in the lesions. These results were statistically significantly different (p&lt;0.01). In 15 patients in the study group, no side effects were reported; the most frequently seen side effects were erythema and erosion. In six patients that were observed for a period of six months, recurrences occurred. Imiquimod 5% cream is a topically applied medicament that should be considered as an effective and reliable medical option in the treatment of anogenital warts.<\/jats:p>","DOI":"10.1111\/j.1346-8138.2004.tb00568.x","type":"journal-article","created":{"date-parts":[[2014,7,22]],"date-time":"2014-07-22T09:36:34Z","timestamp":1406021794000},"page":"627-631","source":"Crossref","is-referenced-by-count":58,"title":["Topical Imiquimod 5% Cream in External Anogenital Warts: A Randomized, Double\u2010Blind, Placebo\u2010Controlled Study"],"prefix":"10.1111","volume":"31","author":[{"given":"Ozer","family":"Arican","sequence":"first","affiliation":[{"name":"Department of Dermatology, Medical Faculty Kahramanmaras Sutcu Imam University  Kahramanmaras Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Funda","family":"Guneri","sequence":"additional","affiliation":[{"name":"Department of Dermatology Haseki Hospital  Istanbul Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaan","family":"Bilgic","sequence":"additional","affiliation":[{"name":"Department of Dermatology Boyabat Hospital  Sinop Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aynur","family":"Karaoglu","sequence":"additional","affiliation":[{"name":"Department of Dermatology Haseki Hospital  Istanbul Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2014,7,22]]},"reference":[{"key":"e_1_2_5_2_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9343(97)00177-0"},{"key":"e_1_2_5_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9343(97)00181-2"},{"key":"e_1_2_5_4_1","doi-asserted-by":"publisher","DOI":"10.1093\/clinids\/20.Supplement_1.S91"},{"key":"e_1_2_5_5_1","doi-asserted-by":"publisher","DOI":"10.1093\/ajcp\/102.6.768"},{"key":"e_1_2_5_6_1","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1001\/jama.1988.03720040025021","article-title":"Natural interferon alfa for treatment of condylomata acuminata","volume":"259","author":"Friedman\u2010Kien AE","year":"1988","journal-title":"JAMA"},{"key":"e_1_2_5_7_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198610233151704"},{"key":"e_1_2_5_8_1","first-page":"89","article-title":"Preclinical pharmacology and efficacy of immunomodulator candidate R\u2010837","volume":"9","author":"Weeks CE","year":"1989","journal-title":"J Interferon Res"},{"key":"e_1_2_5_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/0166-3542(88)90152-0"},{"key":"e_1_2_5_10_1","first-page":"123","article-title":"Effects of treatment with an oral interferon inducer, imidazoquinolinamine (R\u2010837), on the growth of mouse bladder carcinoma FBC","volume":"10","author":"Sidky YA","year":"1990","journal-title":"J Interferon Res"},{"key":"e_1_2_5_11_1","first-page":"71","article-title":"Effects of a novel topical immunomodulator, imiquimod on keratinocyte cytokine gene expression","volume":"13","author":"Sauder DN","year":"1994","journal-title":"Lymphokine Cytokine Res"},{"key":"e_1_2_5_12_1","doi-asserted-by":"publisher","DOI":"10.1086\/517472"},{"key":"e_1_2_5_13_1","first-page":"257","article-title":"Oral R\u2010837 induces interferon in healthy volunteers","volume":"32","author":"Wick KA","year":"1991","journal-title":"Proc Am Assoc Cancer Res"},{"key":"e_1_2_5_14_1","first-page":"165","article-title":"Imiquimod\u2010an immune response modifier for the treatment of genital warts","volume":"15","author":"Beutner KR","year":"1997","journal-title":"Today's Therapeutic Trends"},{"key":"e_1_2_5_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0190-9622(98)70243-9"},{"key":"e_1_2_5_16_1","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.134.1.25"},{"key":"e_1_2_5_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0733-8635(02)00094-3"},{"key":"e_1_2_5_18_1","doi-asserted-by":"publisher","DOI":"10.1067\/mjd.2000.107806"},{"key":"e_1_2_5_19_1","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.42.4.789"}],"container-title":["The Journal of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1346-8138.2004.tb00568.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1346-8138.2004.tb00568.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,16]],"date-time":"2023-11-16T19:24:37Z","timestamp":1700162677000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1346-8138.2004.tb00568.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,8]]},"references-count":18,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2004,8]]}},"alternative-id":["10.1111\/j.1346-8138.2004.tb00568.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1346-8138.2004.tb00568.x","archive":["Portico"],"relation":{},"ISSN":["0385-2407","1346-8138"],"issn-type":[{"value":"0385-2407","type":"print"},{"value":"1346-8138","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,8]]}}}